Science Abstracts
Toxicological and public good considerations for the regulation of nanomaterial-containing medical products
March 2008
March 2008
Authors : Thomas A Faunce
Affliation : Associate Professor and Director Globalisation and Health Project Australian National University Medical School and College of Law, College of Law, Fellows Road, Acton, Canberra ACT 0200, Australia Thomas.Faunce@anu.edu.au
DOI : 10.1517/14740338.7.2.103
Published in : Expert Opin. Drug Saf. Volume 7 Issue 2 2008 pages 103 106
Subject: Editorials
Keywords: nanomedicine , nanotechnology , regulation , toxicology
Abstract
Increasing research interest in the new and unusual...
Please Login to read the full article.
RELATED CONTENT
NEWS
- US Capitol Capsule: Obama backs NCATS, reveals plans to move ideas from lab to market
- YM BioSciences rises on PhI/II results showing promise for JAK1/JAK2 inhibitor for myelofibrosis
- FDA reviewers question proposed study design for Salix's Xifaxan in IBS
- US Capitol Capsule: In belt-tightening climate, FDA chief remains 'guardedly optimistic' for 2012
COMMENT
Other Informa Comment
EVENTS
26 February 2012
Vancouver Convention Centre | Vancouver, BC, Canada
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
